prof. Sylvie Rottey
Show
Sort by
-
Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium
-
A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory
-
Sharp rise in the expenditures of targeted drugs in Ecuador : five-year (2010-2014) consumption of oncologic drugs in public and private hospitals
-
A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder : is there a link between metastasis and factor deficiency in solid tumors?
-
Pembrolizumab for the treatment of bladder cancer
-
Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial
-
Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents
-
Congress highlights : ESMO 2017 special edition : highlights in genitourinary cancers
-
Highlights in genitourinary cancers from the 2017 ASCO Genitourinary Cancers Symposium
-
Phenotyping of the immune infiltrate in oropharyngeal squamous cell carcinoma : focus on materials and methods